These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37543661)

  • 41. Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model.
    Bogart M; Liu Y; Oakland T; Stiegler M
    Int J Chron Obstruct Pulmon Dis; 2022; 17():735-747. PubMed ID: 35418750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Machine learning-enabled risk prediction of chronic obstructive pulmonary disease with unbalanced data.
    Wang X; Ren H; Ren J; Song W; Qiao Y; Ren Z; Zhao Y; Linghu L; Cui Y; Zhao Z; Chen L; Qiu L
    Comput Methods Programs Biomed; 2023 Mar; 230():107340. PubMed ID: 36640604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of the COPD Assessment Test respiratory item score on the decision to hospitalize patients with disease exacerbation in a hospital emergency department.
    Pulido Herrero E; Villanueva Etxebarria A; Aramburu Ojembarrena A; Piñera Salmerón P; Quintana López JM; Esteban González C; Gallardo Rebollal MS; Amigo Angulo JM; Urrutikoetxea Etxebarria S; Ibarrola Luengas I; Armentia Bardeci JM; García Gutiérrez S
    Emergencias; 2022 Apr; 34(2):95-102. PubMed ID: 35275459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acutely decompensated heart failure with chronic obstructive pulmonary disease: Clinical characteristics and long-term survival.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Raimondo R; Venezia M; Frigerio M
    Eur J Intern Med; 2019 Feb; 60():31-38. PubMed ID: 30446355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.
    Marcun R; Stankovic I; Vidakovic R; Farkas J; Kadivec S; Putnikovic B; Ilic I; Neskovic AN; Lainscak M
    Intern Emerg Med; 2016 Jun; 11(4):519-27. PubMed ID: 26423072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

  • 47. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Machine learning approaches for predicting disposition of asthma and COPD exacerbations in the ED.
    Goto T; Camargo CA; Faridi MK; Yun BJ; Hasegawa K
    Am J Emerg Med; 2018 Sep; 36(9):1650-1654. PubMed ID: 29970272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Hu WP; Lhamo T; Liu D; Hang JQ; Zhang FY; Zuo YH; Zeng YY; Zhang J
    COPD; 2019 Apr; 16(2):160-167. PubMed ID: 31094228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depressive symptoms and quality of life in elderly patients with exacerbation of chronic obstructive pulmonary disease or cardiac heart failure: preliminary data of a randomized controlled trial.
    Aimonino N; Tibaldi V; Barale S; Bardelli B; Pilon S; Marchetto C; Zanocchi M; Molaschi M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():7-12. PubMed ID: 17317428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
    Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting Severe Chronic Obstructive Pulmonary Disease Exacerbations. Developing a Population Surveillance Approach with Administrative Data.
    Tavakoli H; Chen W; Sin DD; FitzGerald JM; Sadatsafavi M
    Ann Am Thorac Soc; 2020 Sep; 17(9):1069-1076. PubMed ID: 32383971
    [No Abstract]   [Full Text] [Related]  

  • 55. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living at discharge in hospitalized patients with chronic obstructive pulmonary disease exacerbation.
    Murakami Y; Yasui H; Sato J; Uto T; Inui N; Suda T; Imokawa S
    Ther Adv Respir Dis; 2023; 17():17534666231172924. PubMed ID: 37218674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palliative needs for heart failure or chronic obstructive pulmonary disease: Results of a multicenter observational registry.
    Gavazzi A; De Maria R; Manzoli L; Bocconcelli P; Di Leonardo A; Frigerio M; Gasparini S; Humar F; Perna G; Pozzi R; Svanoni F; Ugolini M; Deales A
    Int J Cardiol; 2015 Apr; 184():552-558. PubMed ID: 25767016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Machine Learning Approach to the Interpretation of Cardiopulmonary Exercise Tests: Development and Validation.
    Inbar O; Inbar O; Reuveny R; Segel MJ; Greenspan H; Scheinowitz M
    Pulm Med; 2021; 2021():5516248. PubMed ID: 34158976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body composition parameters and functional status test in predicting future acute exacerbation risk among hospitalized patients with chronic obstructive pulmonary disease.
    Karanikas I; Karayiannis D; Karachaliou A; Papanikolaou A; Chourdakis M; Kakavas S
    Clin Nutr; 2021 Nov; 40(11):5605-5614. PubMed ID: 34656957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application Value of Blood Heparin-Binding Protein in the Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Dong Y; Zhou X; Zhang Y; Liu Y; Zhou X; Ren G; Li Q
    Contrast Media Mol Imaging; 2021; 2021():3800211. PubMed ID: 35024012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.